Picture of Oncoinvent ASA logo

ONCIN — Oncoinvent ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: BerGenBio Q2 Operating Loss For Quarter Widens To NOK 64.7 Mln

Aug 18 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * BERGENBIO ASA: RESULTS FOR THE SECOND QUARTER AND FIRST
HALF OF
2020
    * REVENUE FOR Q2 AMOUNTED TO NOK 0.0 MILLION (NOK 0.0
MILLION)
    * Q2 OPERATING LOSS FOR QUARTER CAME TO NOK 64.7 MILLION
(NOK 52.0
MILLION)
    * TOTAL OPERATING EXPENSES FOR Q2 AMOUNTED TO NOK 64.7
MILLION
(NOK 52.0 MILLION)

Source text for Eikon:  ID:nWkr7f77VY 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Oncoinvent ASA

See all news